Omni Bio Pharmaceutical Appoints Dr #juice #pharma

Posted On Nov 30 2017 by

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …


Omni Bio Pharmaceutical Appoints Dr #zuellig #pharma

Posted On Oct 4 2017 by

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …


Omni Bio Pharmaceutical Appoints Dr #cadence #pharma

Posted On Jul 9 2017 by

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …


Omni Bio Pharmaceutical Appoints Dr #generic #pharmaceuticals

Posted On May 29 2017 by

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …


Omni Bio Pharmaceutical Appoints Dr #pharmaceutical #company #names

Posted On May 14 2017 by

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …


Omni Bio Pharmaceutical Appoints Dr #healthcare #news

Posted On Apr 19 2017 by

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …


Omni Bio Pharmaceutical Appoints Dr #hi #tech #pharma

Posted On Apr 9 2017 by

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …


Omni Bio Pharmaceutical Appoints Dr #pharma #consulting #companies

Posted On Mar 18 2017 by

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …


Omni Bio Pharmaceutical Appoints Dr #future #of #pharmaceutical #industry

Posted On Nov 21 2016 by

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …


Omni Bio Pharmaceutical Appoints Dr #pharma #clinical #trials

Posted On Oct 27 2016 by

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …